- Home
- SKIL vs MIST Comparison
SKIL vs MIST Comparison
Compare SKIL & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKIL
- MIST
- Stock Information
- Founded
- SKIL 1998
- MIST 2003
- Country
- SKIL United States
- MIST Canada
- Employees
- SKIL N/A
- MIST N/A
- Industry
- SKIL Computer Software: Prepackaged Software
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- SKIL Technology
- MIST Health Care
- Exchange
- SKIL Nasdaq
- MIST Nasdaq
- Market Cap
- SKIL 123.2M
- MIST 132.5M
- IPO Year
- SKIL N/A
- MIST N/A
- Fundamental
- Price
- SKIL $15.40
- MIST $1.84
- Analyst Decision
- SKIL
- MIST Strong Buy
- Analyst Count
- SKIL 0
- MIST 2
- Target Price
- SKIL N/A
- MIST $7.50
- AVG Volume (30 Days)
- SKIL 22.8K
- MIST 1.0M
- Earning Date
- SKIL 09-09-2025
- MIST 08-12-2025
- Dividend Yield
- SKIL N/A
- MIST N/A
- EPS Growth
- SKIL N/A
- MIST N/A
- EPS
- SKIL N/A
- MIST N/A
- Revenue
- SKIL $527,402,000.00
- MIST N/A
- Revenue This Year
- SKIL $3.18
- MIST N/A
- Revenue Next Year
- SKIL $2.50
- MIST N/A
- P/E Ratio
- SKIL N/A
- MIST N/A
- Revenue Growth
- SKIL N/A
- MIST N/A
- 52 Week Low
- SKIL $11.87
- MIST $0.63
- 52 Week High
- SKIL $34.43
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- SKIL 52.40
- MIST 63.24
- Support Level
- SKIL $14.30
- MIST $1.62
- Resistance Level
- SKIL $16.25
- MIST $1.73
- Average True Range (ATR)
- SKIL 0.63
- MIST 0.09
- MACD
- SKIL 0.13
- MIST 0.02
- Stochastic Oscillator
- SKIL 61.26
- MIST 78.33
About SKIL Skillsoft Corp.
Skillsoft Corp is a leader in corporate digital learning. The company's segment includes Talent Development Solutions and Global Knowledge. Talent Development Solutions brings a foundation of products and customers. TDS enterprise-grade solution serves customers and employees world-wide. TDS Learner is a world-renowned consumer-scale and experience learner platform that serves learners world-wide. The Global Knowledge segment is centered around instructor-led training, or live learning, with face-to-face delivery by experienced trainers, both in-person and virtually.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).